PharmEasy acquires 66% stake in Thyrocare Tech for Rs 4,546 crore
Thyrocare Technologies Limited is a chain of diagnostic and preventive care laboratories
Docon Technologies, a unit of PharmEasy’s parent company API Holdings Ltd, will acquire the majority stake in the diagnostic chain
The acquisition will trigger an open offer for the purchase of an additional 26% stake in the company
The open offer will be made at Rs 1,300 per share, which could cost Docon Rs 1,780 crore if public shareholders tender their shares
Thyrocare chairman A. Velumani will acquire a stake of less than 5% in API Holdings
This is PharmEasy’s third acquisition after Ascent Health and Medlife
The acquisition of Medlife has made PharmEasy India’s largest online pharmacy
